Evidence map›Paper›PMID 27233506›Full record

ArticleRheumatology international2016

Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region.

Tarek Carlos Salman-Monte, Vicenç Torrente-Segarra, M Almirall, Patricia Corzo, Sergi Mojal, Jordi Carbonell-Abelló

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tarek Carlos Salman-MonteRheumatology Department, Parc de Salut Mar, IMIM, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalunya, Spain.
Vicenç Torrente-SegarraRheumatology Department, Hospital General Hospitalet-Moisès Broggi, Hospitalet Llobregat, Catalunya, Spain. vtorrente@hsjdbcn.org.
M AlmirallRheumatology Department, Parc de Salut Mar, IMIM, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalunya, Spain.
Patricia CorzoRheumatology Department, Parc de Salut Mar, IMIM, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalunya, Spain.
Sergi MojalUnitat de Assessorament Metodològic a la Investigació, Biomèdica (AMIB), Barcelona, Catalunya, Spain.
Jordi Carbonell-AbellóRheumatology Department, Parc de Salut Mar, IMIM, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalunya, Spain.
Universitat Autònoma de Barcelona · ESCentro de Investigación Biomédica en Red · ESParc de Salut · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been previously reported that vitamin D deficiency is more prevalent among SLE patients than in the general population. We sought to determine the prevalence of vitamin D insufficiency and deficiency and their related factors, its relationship to SLE symptoms and disease activity on a group of supplemented and non-supplemented female SLE patients from the Mediterranean region. We performed a cross-sectional study including female SLE patients who regularly attended the outpatient Lupus Unit at Parc de Salut Mar-IMAS in Barcelona, from January 2012 to May 2014. Collected data were sociodemographics, vitamin D supplementation, fatigue degree visual analog scale, pharmacological treatment, main SLE serological markers, indexes, scales and plasma levels of 25-hydroxyvitamin D. One hundred and two consecutive female SLE patients were included. Vitamin D overall insufficiency and deficiency were exhibited by 46 and 22.5 % of patients, respectively. Vitamin D insufficiency was found in 50 % of supplemented and 60 % of non-supplemented patients. Among non-supplemented female SLE patients, it was found that patients with vitamin D insufficiency showed more fatigue (p = 0.009) and received more oral corticosteroids (p = 0.02) than those with normal levels. Patients with vitamin D insufficiency (supplemented and non-supplemented) received more oral corticosteroids than those without insufficiency (p = 0.008). Vitamin D insufficiency is highly prevalent among female SLE patients, even in southern regions. Non-supplemented female SLE patients showed more fatigue and received more oral corticosteroids than those with normal levels of vitamin D. These data were not found in supplemented patients although having a high prevalence of vitamin D insufficiency (up to 50 %). Further studies with longer follow-up and larger population are needed to confirm our observations.

Indexed as

Dietary SupplementsAdministration, OralAdrenal Cortex HormonesAdultAgedBiomarkersCross-Sectional StudiesFemaleHumansLupus Erythematosus, SystemicMiddle AgedPrevalenceRisk FactorsSpainTime FactorsTreatment Outcome25-hydroxyvitamin DAdrenal Cortex HormonesBiomarkersVitamin DFatigueSLEDAISystemic lupus erythematosusVitamin D insufficiency

Identifiers

PMID27233506
OpenAlexW2397817025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.